Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

Novel anti-HIV compound acts by inhibiting HIV-1 transcription

March 11, 1998

Ritonavir in advanced HIV-1 disease

March 9, 1998

Viracept approved in Japan

March 9, 1998

FDA will give priority review to nitazoxanide

March 6, 1998

More on anti-HIV research at Glaxo Wellcome

March 4, 1998

ArQule and Sepracor to optimize lead antiinfective compounds

March 4, 1998

Additional phase I/II data reported for Panretin Gel in KS

March 3, 1998

Cyclopropane analogues as potent anti-HIV-1 agents

Feb. 26, 1998

Agouron discloses new HIV protease inhibitors

Feb. 26, 1998

Tripos and Sepracor to collaborate on discovery of HIV protease inhibitors

Feb. 26, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....